Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients.
Conclusion: The present study shows a very low prevalence of DILI among high-dose ZLM abusers. The prevalence of hypertransaminasemia was in line with general population. On one hand ZLM has a substantially safe liver profile but on the other hand ZLM abuse and dependence, especially at very high doses, represents an emerging problem.
PMID: 31177863 [PubMed - as supplied by publisher]
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research
More News: Ambien | Drugs & Pharmacology | Liver | Sleep Disorders | Sleep Medicine | Study | Substance Abuse | Toxicology | Urology & Nephrology